Clinical Trials Logo

Localized Prostate Cancer clinical trials

View clinical trials related to Localized Prostate Cancer.

Filter by:

NCT ID: NCT00717613 Completed - Clinical trials for Localized Prostate Cancer

Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting

Start date: July 2007
Phase: N/A
Study type: Observational

This study includes an interview with men who have selected "watchful waiting" or "active surveillance" for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation). We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.

NCT ID: NCT00651417 Recruiting - Clinical trials for Localized Prostate Cancer

Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue

Start date: April 2005
Phase: Phase 2
Study type: Interventional

Participants will be diagnosed with localized prostate or breast cancer and be scheduled to undergo external beam radiation therapy. Participants will either receive a placebo or organic germanium to be taken 5 times a day starting the day of their first radiation and continuing through the 1 month follow-up visit. Weekly Quality of life forms will be completed through the one month follow up visit and then at the 3 month follow up visit. Labs will be done prior to the start of treatment, at the end of treatment and at the one and three month follow-up visits.

NCT ID: NCT00196781 Completed - Clinical trials for Localized Prostate Cancer

Treatment Decision Making in Early-Stage Prostate Cancer

Start date: September 2002
Phase: Phase 3
Study type: Interventional

We plan to test the effectiveness of a recently developed computer-based program that is designed to improve patient knowledge about prostate cancer treatments. It is also designed to help men clarify their values using a computer-based 'decision aid.' A decision aid gives patients tools to help them understand their own values and how these values may be related to their choice of different forms of therapy for prostate cancer. In order to test the effectiveness of the decision aid, men will be assigned on a chance basis to receive either 1) the computer program that includes the information about prostate cancer treatments alone, or 2) the computer program that contains both the information and the decision aid. We expect that men in decision aid group will be more active in their treatment decision and will have improved knowledge, quality of life, and satisfaction with the treatment decision relative to men who only receive the information.